相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β
Pu Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Jose Joaquin Merino et al.
CURRENT ALZHEIMER RESEARCH (2016)
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Dario Tejera et al.
CURRENT ALZHEIMER RESEARCH (2016)
Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO, and PGE2 expression and inhibits NF-κB signaling in a mouse model of Alzheimer's disease
Shi Shi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Higher brain BDNF gene expression is associated with slower cognitive decline in older adults
Aron S. Buchman et al.
NEUROLOGY (2016)
Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
Rachelle Balez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons
Bianca Seifert et al.
NEURAL PLASTICITY (2016)
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Rachana Shah et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
The role of nitric oxide in the object recognition memory
Nikolaos Pitsikas
BEHAVIOURAL BRAIN RESEARCH (2015)
Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
Nicole Maphis et al.
BRAIN (2015)
Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease
Zhen Fan et al.
BRAIN (2015)
Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease
Ulrike Flierl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Fractalkine (CX3CL1): A Biomarker Reflecting Symptomatic Severity in Patients With Knee Osteoarthritis
Li Wei Huo et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ
S. Strobel et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
Heidi Y. Febinger et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Arginase 1+microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
Jonathan D. Cherry et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Nitric Oxide Signaling Is Recruited As a Compensatory Mechanism for Sustaining Synaptic Plasticity in Alzheimer's Disease Mice
Shreaya Chakroborty et al.
JOURNAL OF NEUROSCIENCE (2015)
Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease
Anand Kamal Sachdeva et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Fractalkine Over Expression Suppresses alpha-Synuclein-mediated Neurodegeneration
Kevin R. Nash et al.
MOLECULAR THERAPY (2015)
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Hirohide Asai et al.
NATURE NEUROSCIENCE (2015)
Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach
Andrew F. Teich et al.
NEUROTHERAPEUTICS (2015)
Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
Jenny Dworzak et al.
PLOS ONE (2015)
Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability
Xiaolin Zhang et al.
THROMBOSIS RESEARCH (2015)
Associations of cytokine genes with Alzheimer's disease and depression in an elderly Korean population
Hee-Ju Kang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer's Disease
Ai-Guo Xuan et al.
MOLECULAR NEUROBIOLOGY (2015)
Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
Maria Pedraz et al.
PLOS ONE (2015)
Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease
Aaron D. Thome et al.
PLOS ONE (2015)
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment
Kazuya Fukumoto et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Isabel Lastres-Becker et al.
BRAIN (2014)
Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: Modulation by NOS inhibitors
Ahmed Maher et al.
BRAIN RESEARCH BULLETIN (2014)
Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis
Sergio Martinez-Hervas et al.
CARDIOVASCULAR RESEARCH (2014)
Targeting TNF: a therapeutic strategy for Alzheimer's disease
Xin Cheng et al.
DRUG DISCOVERY TODAY (2014)
Transcriptome Profiling Analysis of the Mechanisms Underlying the BDNF Val66Met Polymorphism Induced Dysfunctions of the Central Nervous System
Dong-Dong Wang et al.
HIPPOCAMPUS (2014)
Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride
Salvatore Giunta et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets
Denes Zadori et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Apolipoprotein E4 Impairs in vivo Hippocampal Long-Term Synaptic Plasticity by Reducing the Phosphorylation of CaMKII alpha and CREB
Feng Qiao et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
IFN-γ and TNF-α Are Involved During Alzheimer Disease Progression and Correlate with Nitric Oxide Production: A Study in Algerian Patients
Mourad Belkhelfa et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging
Eduardo Rigon Zimmer et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway
Sungho Lee et al.
JOURNAL OF NEUROSCIENCE (2014)
Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease
Ping Jiang et al.
MOLECULAR MEDICINE REPORTS (2014)
Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
Elisa Ferretti et al.
MEDIATORS OF INFLAMMATION (2014)
Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
Cecilia E. Hanzel et al.
NEUROBIOLOGY OF AGING (2014)
Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
Kiran Bhaskar et al.
NEUROBIOLOGY OF DISEASE (2014)
Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease
Fatima Rivera-Escalera et al.
NEUROBIOLOGY OF DISEASE (2014)
CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
Mads Kruger Falk et al.
PLOS ONE (2014)
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo
Igor Klyubin et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Why calcium channel blockers could be an elite choice in the treatment of Alzheimer's disease: a comprehensive review of evidences
Ponne Saravanaraman et al.
REVIEWS IN THE NEUROSCIENCES (2014)
CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome
Elisa Astorri et al.
RHEUMATOLOGY (2014)
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity
Graham K. Sheridan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Long-term potentiation can be induced in the CA1 region of hippocampus in the absence of αCaMKII T286-autophosphorylation
Agnes Villers et al.
LEARNING & MEMORY (2014)
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
Patrick L. McGeer et al.
ACTA NEUROPATHOLOGICA (2013)
Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
Stavros Apostolakis et al.
ACTA PHARMACOLOGICA SINICA (2013)
Chronic Neuron- and Age-Selective Down-Regulation of TNF Receptor Expression in Triple-Transgenic Alzheimer Disease Mice Leads to Significant Modulation of Amyloid- and Tau-Related Pathologies
Sara L. Montgomery et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor
Christopher N. Parkhurst et al.
CELL (2013)
TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer's β-Amyloid Oligomers in Mice and Monkeys
Mychael V. Lourenco et al.
CELL METABOLISM (2013)
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy
Qin Zhihui
FUTURE MEDICINAL CHEMISTRY (2013)
Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology
Susan A. Austin et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
Hayley A. Mattison et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
Myriam Catalano et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Fractalkine (CX(3)CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A(2A)R) activity
Maria Scianni et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Involvement of interleukin-1β in the autophagic process of microglia: relevance to Alzheimer's disease
Arnaud Francois et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer's Disease
Chengbo Meng et al.
JOURNAL OF NEUROSCIENCE (2013)
Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Kevin R. Nash et al.
NEUROBIOLOGY OF AGING (2013)
Enhanced Expression of Glia Maturation Factor Correlates with Glial Activation in the Brain of Triple Transgenic Alzheimer's Disease Mice
Smita Zaheer et al.
NEUROCHEMICAL RESEARCH (2013)
Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β
Zhi-Cong Wang et al.
NEUROSCIENCE BULLETIN (2013)
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer's Disease Brain
Megan M. Varnum et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Chronic IL-1β-Mediated Neuroinflammation Mitigates Amyloid Pathology in a Mouse Model of Alzheimer's Disease without Inducing Overt Neurodegeneration
Sarah B. Matousek et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis
Ljiljana Stojkovic et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease
Josh M. Morganti et al.
JOURNAL OF NEUROSCIENCE (2012)
Neuroinflammation and Synaptic Loss
Jagadeesh S. Rao et al.
NEUROCHEMICAL RESEARCH (2012)
Complement-Mediated Microglial Clearance of Developing Retinal Ganglion Cell Axons
Carolyn M. Tyler et al.
NEURON (2012)
Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
Huili Zhang et al.
PLOS ONE (2012)
Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions
Brian Jones et al.
FRONTIERS IN IMMUNOLOGY (2012)
Ablation of TNF-RI/RII Expression in Alzheimer's Disease Mice Leads to an Unexpected Enhancement of Pathology Implications for Chronic Pan-TNF-α Suppressive Therapeutic Strategies in the Brain
Sara L. Montgomery et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Bradley T. Hyman
ARCHIVES OF NEUROLOGY (2011)
In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Ki-Wook Kim et al.
BLOOD (2011)
Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression
Mariko Noda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease
Seo-Hyun Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
Mibel M. Pabon et al.
JOURNAL OF NEUROINFLAMMATION (2011)
CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity
Justin T. Rogers et al.
JOURNAL OF NEUROSCIENCE (2011)
CX3CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment
Laura Maggi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2011)
CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models
Sungho Lee et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients
Xin Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes
S. Piccinin et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis
Zhiqiang Liu et al.
JOURNAL OF NEUROSCIENCE (2010)
Microglia in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2010)
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Kiran Bhaskar et al.
NEURON (2010)
Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death
Clotilde Lauro et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro
Anthony Lyons et al.
JOURNAL OF NEUROCHEMISTRY (2009)
LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)
Laura Maggi et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Does neuroinflammation fan the flame in neurodegenerative diseases?
Tamy C. Frank-Cannon et al.
MOLECULAR NEURODEGENERATION (2009)
Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease
Jose L. Albasanz et al.
BRAIN PATHOLOGY (2008)
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation ROLE OF THE TRANSMEMBRANE DOMAIN
Patricia Hermand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
Melissa K. Mccoy et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor
Shirley Wakselman et al.
JOURNAL OF NEUROSCIENCE (2008)
Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease
Tae-Suk Kim et al.
NEUROSCIENCE LETTERS (2008)
Decreased fractalkine and increased IP-10 expression in aged brain of APPswe transgenic mice
Rui-Sheng Duan et al.
NEUROCHEMICAL RESEARCH (2008)
Neuronal 'On' and 'Off' signals control microglia
Knut Biber et al.
TRENDS IN NEUROSCIENCES (2007)
Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
Ping He et al.
JOURNAL OF CELL BIOLOGY (2007)
Perineuronal nets protect against amyloid β-protein neurotoxicity in cultured cortical neurons
Seiji Miyata et al.
BRAIN RESEARCH (2007)
Interferon-γ and tumor necrosis factor-a regulate amyloid-α plaque deposition and β-secretase expression in Swedish mutant APP transgenic mice
Masaru Yamamoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons
Davide Ragozzino et al.
JOURNAL OF NEUROSCIENCE (2006)
Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices
Cristina Bertollini et al.
NEUROPHARMACOLOGY (2006)
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E. Cardona et al.
NATURE NEUROSCIENCE (2006)
Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity
C Limatola et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
Microglia promote the death of developing Purkinje cells
JL Marín-Teva et al.
NEURON (2004)
Production and neuroprotective functions of fractalkine in the central nervous system
T Mizuno et al.
BRAIN RESEARCH (2003)
Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
O Meucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms
G Halliday et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
分享论文
